145 related articles for article (PubMed ID: 16854593)
1. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
2. Potent anti-tumor and prolonged survival effects of E. coli-derived non-glycosylated kringle domain of tissue-type plasminogen activator.
Kang BH; Shim BS; Lee SY; Lee SK; Hong YK; Joe YA
Int J Oncol; 2006 Feb; 28(2):361-7. PubMed ID: 16391790
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
4. The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growth.
Shim BS; Kang BH; Hong YK; Kim HK; Lee IH; Lee SY; Lee YJ; Lee SK; Joe YA
Biochem Biophys Res Commun; 2005 Feb; 327(4):1155-62. PubMed ID: 15652516
[TBL] [Abstract][Full Text] [Related]
5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
6. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
Lee BH; Kim HK; Joe YA
Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
[TBL] [Abstract][Full Text] [Related]
7. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
8. [Expression and characterization of Kringle 1-4.5 domains of human plasminogen].
Zhou QW; Xie JL; Xin L; Xu R; Ye Q; Li ZP; Gan RB
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):138-42. PubMed ID: 12545220
[TBL] [Abstract][Full Text] [Related]
9. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
Kim HK; Joe YA
Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
11. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
12. Expression of kringle 5 domain of human plasminogen in Pichia pastoris.
Zhu M; Cheng J; Hua ZC
Prep Biochem Biotechnol; 2003 Nov; 33(4):269-81. PubMed ID: 14606685
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
14. [Expression and characterization of Kringle 1-5 domains of human plasminogen].
Zhou QW; Xie JL; Xin L; Ye Q; Li ZP; Gan RB
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Aug; 35(8):761-7. PubMed ID: 12897974
[TBL] [Abstract][Full Text] [Related]
15. [Molecular cloning and expression of the cDNA encoding angiogenesis inhibitor K4K5 with Pichia pastoris].
Guan XQ; Wang YX; Wu LC; Song HY
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):126-30. PubMed ID: 11411216
[TBL] [Abstract][Full Text] [Related]
16. [Cloning and expression of kringle 1-3 gene of human plasminogen and the purification and bioactivity of its expressed product].
Zhang TY; Luo JX; Lu XY
Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):593-6. PubMed ID: 12561205
[TBL] [Abstract][Full Text] [Related]
17. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
[TBL] [Abstract][Full Text] [Related]
18. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
[TBL] [Abstract][Full Text] [Related]
20. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
